-+ 0.00%
-+ 0.00%
-+ 0.00%

NovaBridge Biosciences CEO, director Srishti Gupta files initial beneficial ownership statement

PUBT·07/08/2026 20:25:07
Listen to the news
NovaBridge Biosciences CEO, director Srishti Gupta files initial beneficial ownership statement
  • NovaBridge Biosciences filed a Form 3 naming Srishti Gupta as chief executive officer, disclosing her initial insider holdings as of July 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002024011-26-000004), on July 08, 2026, and is solely responsible for the information contained therein.